Back
Syndax Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
60
SNDX
Syndax Pharmaceuticals
Last Price:
20.82
Seasonality Move:
6.88%
Sell
23
ALNY
Alnylam Pharmaceuticals
Last Price:
143.82
Seasonality Move:
18.17%
Buy
60
Syndax Pharmaceuticals (SNDX)
is a Buy
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $20.97. The Score for SNDX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SNDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $146.06. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $20.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $146.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
SNDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 40.56 | Sell |
Chaikin Money Flow: | -700030 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.27 - 23.25) | Sell |
Bollinger Bands (100): | (19.54 - 23.46) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.12 | Sell |
Relative Strength Index (14 RSI): | 40.22 | Sell |
Chaikin Money Flow: | -278006 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (146.31 - 153.19) | Sell |
Bollinger Bands (100): | (149.67 - 184.09) | Sell |
SNDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.08 | Sell |
20-day SMA: | 22.17 | Sell |
50-day SMA: | 22.71 | Sell |
200-day SMA: | 19.06 | Buy |
8-day EMA: | 21.19 | Sell |
20-day EMA: | 21.84 | Sell |
50-day EMA: | 22.06 | Sell |
200-day EMA: | 20.46 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 146.22 | Sell |
20-day SMA: | 150.11 | Sell |
50-day SMA: | 151.47 | Sell |
200-day SMA: | 173.62 | Sell |
8-day EMA: | 146.77 | Sell |
20-day EMA: | 148.88 | Sell |
50-day EMA: | 154.08 | Sell |
200-day EMA: | 170.89 | Sell |
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and an increase next year of $1.08 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.42 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.51 per share, and an increase next year of $1.82 per share.
Syndax Pharmaceuticals Technical Analysis
Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |